National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- Access to Care (5)
- Adverse Drug Events (ADE) (46)
- Adverse Events (10)
- Alcohol Use (3)
- Ambulatory Care and Surgery (6)
- Antibiotics (9)
- Antimicrobial Stewardship (8)
- Arthritis (10)
- Asthma (8)
- Behavioral Health (21)
- Blood Clots (1)
- Blood Pressure (7)
- Blood Thinners (5)
- Brain Injury (1)
- Cancer (7)
- Cancer: Breast Cancer (5)
- Cancer: Colorectal Cancer (4)
- Cancer: Prostate Cancer (2)
- Cardiovascular Conditions (17)
- Care Management (9)
- Case Study (1)
- Children/Adolescents (25)
- Chronic Conditions (12)
- Clinical Decision Support (CDS) (5)
- Clinician-Patient Communication (3)
- Clostridium difficile Infections (1)
- Communication (7)
- Community-Based Practice (2)
- Comparative Effectiveness (35)
- Complementary and Alternative Medicine (2)
- Critical Care (2)
- Data (2)
- Decision Making (5)
- Dementia (2)
- Depression (5)
- Diabetes (21)
- Diagnostic Safety and Quality (4)
- Digestive Disease and Health (4)
- Disparities (3)
- Education: Academic (1)
- Education: Patient and Caregiver (5)
- Elderly (30)
- Electronic Health Records (EHRs) (14)
- Electronic Prescribing (E-Prescribing) (1)
- Emergency Department (3)
- Emergency Medical Services (EMS) (5)
- Evidence-Based Practice (12)
- Falls (1)
- Genetics (4)
- Guidelines (7)
- Healthcare-Associated Infections (HAIs) (3)
- Healthcare Costs (13)
- Healthcare Delivery (1)
- Healthcare Utilization (10)
- Health Information Technology (HIT) (20)
- Health Insurance (5)
- Health Literacy (2)
- Health Services Research (HSR) (3)
- Health Systems (1)
- Heart Disease and Health (17)
- Hepatitis (3)
- Hospital Discharge (3)
- Hospitalization (2)
- Hospital Readmissions (2)
- Hospitals (4)
- Human Immunodeficiency Virus (HIV) (10)
- Infectious Diseases (1)
- Injuries and Wounds (3)
- Inpatient Care (2)
- Intensive Care Unit (ICU) (2)
- Kidney Disease and Health (6)
- Lifestyle Changes (1)
- Long-Term Care (3)
- Low-Income (3)
- Maternal Care (2)
- Medicaid (13)
- Medical Devices (2)
- Medical Errors (7)
- Medical Expenditure Panel Survey (MEPS) (2)
- Medicare (13)
- (-) Medication (261)
- Medication: Safety (32)
- Men's Health (1)
- Methicillin-Resistant Staphylococcus aureus (MRSA) (1)
- Mortality (4)
- Neurological Disorders (1)
- Newborns/Infants (3)
- Nursing Homes (9)
- Obesity (4)
- Obesity: Weight Management (1)
- Opioids (18)
- Organizational Change (2)
- Osteoporosis (2)
- Outcomes (10)
- Pain (7)
- Palliative Care (1)
- Patient-Centered Healthcare (5)
- Patient-Centered Outcomes Research (24)
- Patient Adherence/Compliance (29)
- Patient and Family Engagement (1)
- Patient Safety (32)
- Patient Self-Management (2)
- Policy (12)
- Practice-Based Research Network (PBRN) (1)
- Practice Patterns (19)
- Pregnancy (5)
- Prevention (14)
- Primary Care (9)
- Provider (2)
- Provider: Nurse (1)
- Provider: Pharmacist (7)
- Provider: Physician (1)
- Public Reporting (1)
- Quality Indicators (QIs) (1)
- Quality Measures (2)
- Quality of Care (6)
- Quality of Life (2)
- Racial and Ethnic Minorities (9)
- Registries (5)
- Research Methodologies (7)
- Respiratory Conditions (9)
- Risk (15)
- Screening (1)
- Sexual Health (1)
- Sleep Problems (3)
- Social Determinants of Health (3)
- Stroke (1)
- Substance Abuse (14)
- Surgery (8)
- Tobacco Use (2)
- Tools & Toolkits (1)
- Transplantation (2)
- Trauma (1)
- Treatments (6)
- U.S. Preventive Services Task Force (USPSTF) (5)
- Uninsured (1)
- Urban Health (1)
- Vaccination (1)
- Vulnerable Populations (3)
- Web-Based (2)
- Women (6)
- Young Adults (1)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 25 of 261 Research Studies DisplayedSchmajuk G, Tonner C, Miao Y
Folic acid supplementation is suboptimal in a national cohort of older veterans receiving low dose oral methotrexate.
The authors aimed to determine the prevalence, predictors of, and persistence of folic acid use in a population-based cohort of methotrexate (MTX) users with rheumatic diseases. They found that patients who did not see a rheumatologist were 23% less likely to receive folic acid compared to patients who did have a rheumatologist visit during the baseline period, and after 20 months, only 50% of patients continued to receive folic acid. The authors recommend improving patient safety for users of MTX by standardizing workflows for folic acid supplementation.
AHRQ-funded; HS024412.
Citation: Schmajuk G, Tonner C, Miao Y .
Folic acid supplementation is suboptimal in a national cohort of older veterans receiving low dose oral methotrexate.
PLoS One 2016 Dec 15;11(12):e0168369. doi: 10.1371/journal.pone.0168369.
.
.
Keywords: Elderly, Healthcare Utilization, Medication, Arthritis
Meisel ZF, Metlay JP, Sinnenberg L
A randomized trial testing the effect of narrative vignettes versus guideline summaries on provider response to a professional organization clinical policy for safe opioid prescribing.
The authors compared whether narrative vignettes embedded in the American College of Emergency Physicians (ACEP) daily e-newsletter improved dissemination of the clinical policy to ACEP members, and engagement of members with the clinical policy, compared with traditional summary text. They found that the vignettes outperformed traditional guideline text in promoting engagement with an evidence-based clinical guideline related to opioid prescriptions.
AHRQ-funded; HS021956.
Citation: Meisel ZF, Metlay JP, Sinnenberg L .
A randomized trial testing the effect of narrative vignettes versus guideline summaries on provider response to a professional organization clinical policy for safe opioid prescribing.
Ann Emerg Med 2016 Dec;68(6):719-28. doi: 10.1016/j.annemergmed.2016.03.007.
.
.
Keywords: Communication, Evidence-Based Practice, Guidelines, Opioids, Medication, Medication: Safety, Policy, Provider
Raval AD, Mattes MD, Madhavan S
Association between metformin use and cancer stage at diagnosis among elderly Medicare beneficiaries with preexisting Type 2 diabetes mellitus and incident prostate cancer.
The researchers examined the association between metformin use and cancer stage at diagnosis among elderly men with preexisting diabetes mellitus and incident prostate cancer. They found a significantly lower percentage of metformin users were diagnosed with advanced prostate cancer as compared to nonusers (4.7 percent versus 6.7 percent.
AHRQ-funded; HS018622.
Citation: Raval AD, Mattes MD, Madhavan S .
Association between metformin use and cancer stage at diagnosis among elderly Medicare beneficiaries with preexisting Type 2 diabetes mellitus and incident prostate cancer.
J Diabetes Res 2016;2016:2656814. doi: 10.1155/2016/2656814.
.
.
Keywords: Cancer: Prostate Cancer, Medication, Elderly, Diabetes, Medicare
Westover AN, Nakonezny PA, Adinoff B
Impact of stimulant medication use on heart rate and systolic blood pressure during submaximal exercise treadmill testing in adolescents.
In this study of the impact of stimulant medication use on heart rate and systolic blood pressure during submaximal exercise treadmill testing in adolescents, the investigators found that adolescent stimulant medication users, compared to matched nonusers, demonstrated a trend toward decreased heart rate during submaximal exercise (which is potential evidence of chronic adaptation with stimulant exposure). There was no evidence for delayed heart rate recovery in this study, and thus, no evidence for decreased parasympathetic activity during initial exercise recovery.
AHRQ-funded; HS022418.
Citation: Westover AN, Nakonezny PA, Adinoff B .
Impact of stimulant medication use on heart rate and systolic blood pressure during submaximal exercise treadmill testing in adolescents.
J Child Adolesc Psychopharmacol 2016 Dec;26(10):889-99. doi: 10.1089/cap.2016.0064..
Keywords: Adverse Drug Events (ADE), Children/Adolescents, Blood Pressure, Medication, Medication: Safety
Cho I, Lee JH, Choi J
National rules for drug-drug interactions: are they appropriate for tertiary hospitals?
This study investigated the potential impact of Korean national drug-drug interactions (DDI) rules in a drug utilization review program in terms of their severity coverage and the clinical efficiency of how physicians respond to them. Only 0.3 percent of all of the alerts (n = 66) were high-priority DDI rules. These showed a lower override rate of 51.5 percent, which was much lower than for the overall DDI rules.
AHRQ-funded; HS021094.
Citation: Cho I, Lee JH, Choi J .
National rules for drug-drug interactions: are they appropriate for tertiary hospitals?
J Korean Med Sci 2016 Dec;31(12):1887-96. doi: 10.3346/jkms.2016.31.12.1887.
.
.
Keywords: Adverse Drug Events (ADE), Hospitals, Medication, Medication: Safety
Naples JG, Kotlarczyk MP, Perera S
Non-tricyclic and non-selective serotonin reuptake inhibitor antidepressants and recurrent falls in frail older women.
This study determined the risk of recurrent falls associated with antidepressants other than tricyclics (TCAs) and selective serotonin reuptake inhibitors (SSRIs) among frail older women. At least 15 percent of women experienced recurrent falls between 0-6 and 6-12 months. At baseline and 6 months, 18.2 percent and 6.9 percent had a non-TCA/non-SSRI antidepressant, respectively. It concluded that non-TCA/non-SSRI antidepressant exposure significantly increased the risk of recurrent falls.
AHRQ-funded; HS023779.
Citation: Naples JG, Kotlarczyk MP, Perera S .
Non-tricyclic and non-selective serotonin reuptake inhibitor antidepressants and recurrent falls in frail older women.
Am J Geriatr Psychiatry 2016 Dec;24(12):1221-27. doi: 10.1016/j.jagp.2016.08.008.
.
.
Keywords: Medication, Elderly, Falls, Patient Safety
Flory JH, Ukena JK, Floyd JS
Novel anti-glycemic drugs and reduction of cardiovascular risk in diabetes: expectations realized, promises unmet.
The researchers review evidence on cardiovascular risks and benefits of new treatments for type 2 diabetes mellitus. Their review reports new evidence suggesting that the newest diabetes drugs are safe from a cardiovascular perspective. Evidence on benefit from at least some members of the GLP-1 receptor agonist and SGLT-2 inhibitor classes is encouraging but not yet decisive.
AHRQ-funded; HS023898.
Citation: Flory JH, Ukena JK, Floyd JS .
Novel anti-glycemic drugs and reduction of cardiovascular risk in diabetes: expectations realized, promises unmet.
Curr Atheroscler Rep 2016 Dec;18(12):79. doi: 10.1007/s11883-016-0633-y.
.
.
Keywords: Patient-Centered Outcomes Research, Medication, Diabetes, Cardiovascular Conditions, Risk
Cram P, Wolinsky FD, Lou Y
Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial.
In a clinical trial of 7749 patients, the researchers tested whether usual care augmented by a tailored patient-activation DXA result letter accompanied by an educational brochure would improve guideline-concordant pharmacological treatment compared to usual care only. They found that treatment rates did not improve.
AHRQ-funded; HS023009.
Citation: Cram P, Wolinsky FD, Lou Y .
Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial.
Osteoporos Int 2016 Dec;27(12):3513-24. doi: 10.1007/s00198-016-3681-9.
.
.
Keywords: Education: Patient and Caregiver, Guidelines, Medication, Osteoporosis, Patient and Family Engagement
Merlin JS, Bulls HW, Vucovich LA
Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review.
The authors conducted a systematic review to identify clinical trials and observational studies examining the impact of pharmacologic or non-pharmacologic interventions on pain and/or functional outcomes among HIV-infected individuals with chronic pain in high-development countries. They found that the only included controlled studies with positive results were of capsaicin and cannabis. Among the seven studies of pharmacologic interventions, the authors determined that five had substantial pharmaceutical industry sponsorship. Their findings highlight several important gaps in the HIV/chronic pain literature requiring further research.
AHRQ-funded; HS019465.
Citation: Merlin JS, Bulls HW, Vucovich LA .
Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review.
AIDS Care 2016 Dec;28(12):1506-15. doi: 10.1080/09540121.2016.1191612.
.
.
Keywords: Chronic Conditions, Comparative Effectiveness, Human Immunodeficiency Virus (HIV), Medication, Patient-Centered Outcomes Research
Herrinton LJ, Harrold L, Salman C
Population variations in rheumatoid arthritis treatment and outcomes, Northern California, 1998-2009.
This study assessed variations in rheumatoid arthritis treatment and outcomes at the community level from 1998 through 2009. It found that disease-modifying anti-rheumatic drug use increased in the typical patient from 38 to 63 percent of the time, and oral prednisone use declined from 23 to 15 percent of the time, whereas opioid use initially rose but then fell to 23 percent of the time.
AHRQ-funded; HS019912; HS010391; HS021590; HS018517; HS017919.
Citation: Herrinton LJ, Harrold L, Salman C .
Population variations in rheumatoid arthritis treatment and outcomes, Northern California, 1998-2009.
Perm J 2016 Winter;20(1):4-12. doi: 10.7812/tpp/15-028.
.
.
Keywords: Arthritis, Medication, Comparative Effectiveness, Outcomes
Hallas J, Pottegard A, Wang S
Persistent user bias in case-crossover studies in pharmacoepidemiology.
The authors aimed to assess the occurrence of an upward-biased odds ratio of studying chronic medication exposure and to evaluate whether it is remedied by including a control group. They found that, in case-crossover studies of medications, contamination by persistent users confers a moderate bias upward, which is partly remedied by using a control group.
AHRQ-funded; HS022193.
Citation: Hallas J, Pottegard A, Wang S .
Persistent user bias in case-crossover studies in pharmacoepidemiology.
Am J Epidemiol 2016 Nov 15;184(10):761-69. doi: 10.1093/aje/kww079.
.
.
Keywords: Medication, Research Methodologies
Chou R, Dana T, Blazina I
Statins for prevention of cardiovascular disease in adults: Evidence report and systematic review for the US Preventive Services Task Force.
The purpose of this report systematically reviewed benefits and harms of statins for prevention of cardiovascular disease (CVD), in order to inform the US Preventive Services Task Force. It concluded that in adults at increased CVD risk but without prior CVD events, statin therapy was associated with reduced risk of all-cause and cardiovascular mortality and CVD events, with greater absolute benefits in patients at greater baseline risk.
AHRQ-funded; 2902012000015I.
Citation: Chou R, Dana T, Blazina I .
Statins for prevention of cardiovascular disease in adults: Evidence report and systematic review for the US Preventive Services Task Force.
JAMA 2016 Nov 15;316(19):2008-24. doi: 10.1001/jama.2015.15629.
.
.
Keywords: U.S. Preventive Services Task Force (USPSTF), Prevention, Cardiovascular Conditions, Medication, Evidence-Based Practice
Michaelidis CI, Fine MJ, Lin CJ
The hidden societal cost of antibiotic resistance per antibiotic prescribed in the United States: an exploratory analysis.
This study estimated the hidden societal cost of antibiotic resistance per antibiotic prescribed in the United States. It concluded that each ambulatory antibiotic prescription is associated with a hidden societal cost of antibiotic resistance (SCAR) that substantially increases the cost of an antibiotic prescription in the United States. This finding raises concerns regarding the magnitude of misalignment between individual and societal antibiotic costs.
AHRQ-funded; HS024930.
Citation: Michaelidis CI, Fine MJ, Lin CJ .
The hidden societal cost of antibiotic resistance per antibiotic prescribed in the United States: an exploratory analysis.
BMC Infect Dis 2016 Nov 8;16(1):655. doi: 10.1186/s12879-016-1990-4.
.
.
Keywords: Medication, Primary Care, Hospitalization, Healthcare Costs, Ambulatory Care and Surgery
Hochman MJ, Kamal AH, Wolf SP
Anticholinergic drug burden in noncancer versus cancer patients near the end of life.
This article's objective is to determine anticholinergic load (ACL) and its impact in noncancer versus cancer palliative care patients. The authors concluded that ACL is associated with worse fatigue and quality of life and may not differ significantly between cancer and noncancer patients nearing end of life. Symptom management drugs are more responsible for ACL in cancer and noncancer patients, although disease management drugs contribute significantly to ACL in the latter group. They recommend more attention to reducing anticholinergic use in all patients with life-limiting illness.
AHRQ-funded; HS023681.
Citation: Hochman MJ, Kamal AH, Wolf SP .
Anticholinergic drug burden in noncancer versus cancer patients near the end of life.
J Pain Symptom Manage 2016 Nov;52(5):737-43.e3. doi: 10.1016/j.jpainsymman.2016.03.020.
.
.
Keywords: Adverse Drug Events (ADE), Cancer, Medication, Palliative Care, Quality of Life
Hinkle SN, Mumford SL, Grantz KL
AHRQ Author: Mitchell EM
Association of nausea and vomiting during pregnancy with pregnancy loss: a secondary analysis of a randomized clinical trial.
The researchers examined the association of nausea and vomiting during pregnancy with pregnancy loss. They found that nausea and nausea with vomiting were associated with a reduced risk for clinical pregnancy loss.
AHRQ-authored.
Citation: Hinkle SN, Mumford SL, Grantz KL .
Association of nausea and vomiting during pregnancy with pregnancy loss: a secondary analysis of a randomized clinical trial.
JAMA Intern Med 2016 Nov;176(11):1621-27. doi: 10.1001/jamainternmed.2016.5641.
.
.
Keywords: Adverse Drug Events (ADE), Medication, Pregnancy, Risk, Women
Lipska KJ, Flory JH, Hennessy S
Citizen petition to the US Food and Drug Administration to change prescribing guidelines: The metformin experience.
Although healthcare professionals rarely submit citizen petitions, they can exert a powerful impact on the labeling requirements for drugs. Metformin is one such example. The authors filed 2 petitions to the FDA, asking the FDA to change the label and to relax the renal contraindications. In 2016, the FDA issued a safety communication that partially granted our requests by requiring the manufacturers of metformin to change the labeling of metformin in several ways.
AHRQ-funded; HS023898.
Citation: Lipska KJ, Flory JH, Hennessy S .
Citizen petition to the US Food and Drug Administration to change prescribing guidelines: The metformin experience.
Circulation 2016 Nov 1;134(18):1405-08. doi: 10.1161/circulationaha.116.023041.
.
.
Keywords: Medication, Medication: Safety, Adverse Drug Events (ADE), Kidney Disease and Health, Diabetes
Yazdany J, Robbins M, Schmajuk G
Development of the American College of Rheumatology's rheumatoid arthritis electronic clinical quality measures.
The researchers sought to develop and test electronic clinical quality measures for rheumatoid arthritis. Disease activity assessment, functional status assessment, disease-modifying antirheumatic durg use, and tuberculosis screening measures have achieved national endorsement and are recommended for use in federal quality reporting programs.
AHRQ-funded; HS024412.
Citation: Yazdany J, Robbins M, Schmajuk G .
Development of the American College of Rheumatology's rheumatoid arthritis electronic clinical quality measures.
Arthritis Care Res 2016 Nov;68(11):1579-90. doi: 10.1002/acr.22984.
.
.
Keywords: Electronic Health Records (EHRs), Medication, Quality Measures, Arthritis, Outcomes
Cunha CB, D'Agata EM
Implementing an antimicrobial stewardship program in out-patient dialysis units.
The purpose of this review is to highlight the key elements and interventions of antimicrobial stewardship programs (ASP). The Infectious Disease Society of America and the Society of Healthcare Epidemiology of America have provided evidence-based guidelines for the development and implementation of an ASP. Many of their recommendations can be adapted to the out-patient dialysis setting.
AHRQ-funded; HS021666.
Citation: Cunha CB, D'Agata EM .
Implementing an antimicrobial stewardship program in out-patient dialysis units.
Curr Opin Nephrol Hypertens 2016 Nov;25(6):551-55. doi: 10.1097/mnh.0000000000000281.
.
.
Keywords: Antimicrobial Stewardship, Antibiotics, Medication, Ambulatory Care and Surgery, Kidney Disease and Health, Chronic Conditions
Zullo AR, Dore DD, Gutman R
National glucose-lowering treatment complexity is greater in nursing home residents than community-dwelling adults.
This letter describes common glucose-lowering medication usage patterns for a national cross-section of U.S. adults aged 65 and older residing in nursing home (NH) and community settings from 2007 to 2010. The study results suggest that continued efforts are warranted to improve glucose-lowering medication management and simplify treatment regimens in the NH; that the relative importance of CER questions regarding specific glucose-lowering treatments may differ according to the care setting; and that CER studies of glucose-lowering treatments in older adults must address the combination use of medications, especially in NH residents.
AHRQ-funded; HS022998.
Citation: Zullo AR, Dore DD, Gutman R .
National glucose-lowering treatment complexity is greater in nursing home residents than community-dwelling adults.
J Am Geriatr Soc 2016 Nov;64(11):e233-e35. doi: 10.1111/jgs.14485.
.
.
Keywords: Care Management, Chronic Conditions, Diabetes, Elderly, Medication, Nursing Homes
Banerjee G, Edelman EJ, Barry DT
Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study.
The researchers estimated the influence of non-medical use of prescription opioids on heroin initiation among US veterans receiving medical care. Using a multivariable Cox regression model, they found that non-medical use of prescription opioids was associated positively and independently with heroin initiation.
AHRQ-funded; HS021112; HS023258.
Citation: Banerjee G, Edelman EJ, Barry DT .
Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study.
Addiction 2016 Nov;111(11):2021-31. doi: 10.1111/add.13491.
.
.
Keywords: Medication, Opioids, Substance Abuse
Gagne JJ, Han X, Hennessy S
Successful comparison of US Food and Drug Administration sentinel analysis tools to traditional approaches in quantifying a known drug-adverse event association.
The authors assessed the extent to which the newly developed, semiautomated Sentinel Propensity Score Matching tool could produce the same results as a customized protocol-driven assessment. They found initial evidence that Sentinel analytic tools can produce findings similar to those produced by a highly customized protocol-driven assessment.
AHRQ-funded; HS022193.
Citation: Gagne JJ, Han X, Hennessy S .
Successful comparison of US Food and Drug Administration sentinel analysis tools to traditional approaches in quantifying a known drug-adverse event association.
Clin Pharmacol Ther 2016 Nov;100(5):558-64. doi: 10.1002/cpt.429.
.
.
Keywords: Adverse Drug Events (ADE), Medication, Medication: Safety, Patient Safety
Gaither JR, Goulet JL, Becker WC
The effect of substance use disorders on the association between guideline-concordant long-term opioid therapy and all-cause mortality.
The objective of this study was to determine whether the presence of a substance use disorder (SUD) modifies the association between guideline-concordant care and 1-year all-cause mortality among patients receiving long-term opioid therapy (LtOT) for pain. It found that for clinicians prescribing LtOT to patients with untreated SUDs, engaging patients with psychotherapeutic and SUD treatment services may reduce mortality.
AHRQ-funded; U19 HS021112.
Citation: Gaither JR, Goulet JL, Becker WC .
The effect of substance use disorders on the association between guideline-concordant long-term opioid therapy and all-cause mortality.
J Addict Med 2016 Nov/Dec;10(6):418-28. doi: 10.1097/adm.0000000000000255.
.
.
Keywords: Care Management, Medication, Mortality, Substance Abuse, Opioids, Patient-Centered Outcomes Research
Naples JG, Gellad WF, Hanlon JT
The role of opioid analgesics in geriatric pain management.
This article reviews the epidemiology of opioid use and their effectiveness for chronic noncancer pain (CNCP) in older adults and summarizes important age-related changes in opioid pharmacokinetics and pharmacodynamics that increase the risks of adverse effects in the elderly. Finally, to assist clinicians with selecting appropriate therapy, the article concludes with an evidence-based approach to optimize opioid prescribing in older adults with CNCP.
AHRQ-funded; HS023779.
Citation: Naples JG, Gellad WF, Hanlon JT .
The role of opioid analgesics in geriatric pain management.
Clin Geriatr Med 2016 Nov;32(4):725-35. doi: 10.1016/j.cger.2016.06.006.
.
.
Keywords: Chronic Conditions, Elderly, Medication, Opioids, Pain, Patient Safety
Tiruneh YM, Wilson IB
What time is it? Adherence to antiretroviral therapy in Ethiopia.
This study assessed adherence to antiretroviral therapy (ART) among people living with HIV/AIDS in Ethiopia and explored the sociocultural context in which they relate to their regimen requirements. Its findings indicate that study participants are highly adherent to dose but less adherent to dose schedule. Strict dose time instructions were reported as stressful and unrealistic.
AHRQ-funded; HS000011.
Citation: Tiruneh YM, Wilson IB .
What time is it? Adherence to antiretroviral therapy in Ethiopia.
AIDS Behav 2016 Nov;20(11):2662-73. doi: 10.1007/s10461-016-1322-0.
.
.
Keywords: Patient Adherence/Compliance, Human Immunodeficiency Virus (HIV), Medication
Kesselheim AS, Bykov K, Gagne JJ
Switching generic antiepileptic drug manufacturer not linked to seizures: a case-crossover study.
The researchers estimated the risk of seizure-related events associated with refilling antiepileptic drugs (AED) with generic AEDs and the effect of switching between different manufacturers of the same generic drug. They found that among patients on a generic AED, refilling the same AED was associated with an elevated risk of seizure-related event; however, there was no additional risk from switching during that refill to a different manufacturer.
AHRQ-funded; HS022193.
Citation: Kesselheim AS, Bykov K, Gagne JJ .
Switching generic antiepileptic drug manufacturer not linked to seizures: a case-crossover study.
Neurology 2016 Oct 25;87(17):1796-801. doi: 10.1212/wnl.0000000000003259.
.
.
Keywords: Adverse Drug Events (ADE), Adverse Events, Medication, Medication: Safety, Neurological Disorders, Patient Safety, Risk